The updated COVID-19 shot is expected to offer protection against the new COVID-19 strain JN.1.A new COVID-19 strain has emerged that appears likely to stick around in the U.S. through the holiday season. SEE:
Israel widens 4th COVID-19 booster shot to nursing homes Greece tightens measures as daily COVID-19 cases triple in 48 hours People get COVID-19 test in New York, U.S. Syria starts new vaccination campaign Canada's COVID-19 cases surpass 2.1 million France reports new daily record of CO...
J&J's shot would be the third to be made available in the U.S. and would be distributed through a comparatively simple supply chain: The one-dose regimen eliminates the need to track return visits, and the drug can be stored at less extreme temperatures than vaccines made byPfizerandModerna...
More than a third of people surveyed in Poland and almost half in France - 37% and 48% respectively - said they would say no to a COVID-19 shot if offered it. MORE: Places the U.S. Government Warns Not to Travel Right Now Graphic: YouGov vaccine confi...
New FDA seasonal COVID-19 shot guidance seeks ‘evidence based’ approach The FDA says the new approach will aim to balance a timely approval process for vaccines, while also weighing “the need for evidence" of their effectiveness for the masses. ...
The art of COVID-19 communication Call for global biodiversity agreementModerna said it is looking at whether a booster shot – either of its existing vaccine or of a new shot designed to protect against the South Africa variant – could be made available in future if evidence we...
Alaska, Connecticut, New Mexico, North Dakota and West Virginia lead the country in terms of second doses administered per 100,000 residents. Nearly 25 million additional people in the U.S. have received their first vaccines shot, but the drugs developed byModernaandPfizer-BioNTechare fully prot...
Russia Set to Start Post-Registration Trials for Second COVID-19 Shot More Reuters FILE PHOTO: Russian Deputy Prime Minister Tatiana Golikova attends a session of a coordination council to confront the coronavirus (COVID-19) in Moscow, Russia March 14,...
And while a new poll shows that 80% of adults have either gotten vaccinated against the coronavirus or plan to in the future, that still means that 20% are resisting the shot. The Gallup survey found that 5% of adults reported having had COVID-19 or tes...
Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to seek emergency use of limited shot supplies as the catastrophic outbreak worsens across the globe. The announcement...